High-intensity Exercise Training or Multidisciplinary Treatment in Extremely Obese Adolescents

This study has been completed.
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
First received: May 20, 2008
Last updated: January 5, 2012
Last verified: January 2012
The aim of the present study was to determine the effects of a multidisciplinary approach and intensity-controlled interval training on cardiovascular risk factors in overweight adolescents

Condition Intervention
Cardiovascular Diseases
Behavioral: intensity controlled interval training (AIT)
Behavioral: Multidisciplinary approach (MTG)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Reducing Cardiovascular Risk Factors In Overweight Adolescents: Multidisciplinary Treatment and Intensity Controlled Interval Training

Resource links provided by NLM:

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • Flow mediated Diameter Maximal oxygen uptake BMI [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Enrollment: 54
Study Start Date: February 2004
Study Completion Date: March 2008
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Aerobic interval training
intensity-controlled interval training
Behavioral: intensity controlled interval training (AIT)
4 x 4 min intervals at 90% of maximal heart rate, each interval separated by 3 min at 70%, twice a week for 3 months
Experimental: MTG
multidisciplinary approach
Behavioral: Multidisciplinary approach (MTG)
exercise, dietary and psychological advice, twice a month for 12 months


Ages Eligible for Study:   13 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • BMI >+ 2SD (age adjusted)
  • Fitted for group treatment
  • at least one parent attending the treatment

Exclusion Criteria:

  • Not able to join treatment
  • not able to walk
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00682266

St. Olavs Hospital
Trondheim, Norway, 7006
Sponsors and Collaborators
Norwegian University of Science and Technology
Study Director: Rønnaug Ødegård, Dr.med St. Olavs Hospital
  More Information

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00682266     History of Changes
Other Study ID Numbers: 251076 
Study First Received: May 20, 2008
Last Updated: January 5, 2012
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by Norwegian University of Science and Technology:
multidisciplinary approach
Oxygen uptake
Flow mediated dilatation
Cardiovascular Risk Factors

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on April 27, 2016